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Abstract: 
We investigated clinical factors associated with seizure clustering in patients with drug-resistant 
focal epilepsy and any association between seizure clustering and outcome after surgery. We 
performed a retrospective study including patients with a diagnosis of drug-resistant focal 
epilepsy who underwent epilepsy surgery. Patients were prospectively registered in a database 
from 1986 until 2015. Seizure cluster was defined as two or more seizures occurring within two 
days. Potential risk factors for seizure clustering were assessed. To investigate any potential 
association between seizure clusters and seizure outcome after surgery, time to event analysis 
was used to produce a Kaplan-Meier estimate of seizure recurrence. We studied 764 patients. 
Seizure clusters were reported in 23.6% of TLE patients and 16.9% of extratemporal patients (p 
= 0.2). We could not identify any significant clinical factors associated with seizure clustering. 
Among patients with TLE, those who had history of seizure clusters fared better after surgery (p 
< 0.01). We found that seizure clusters relate to prognosis after anterior temporal lobectomy in 
drug-resistant temporal lobe epilepsy. This data may provide added value for surgical 
prognostication when combined with other data types. A better understanding of the 
neurobiology underlying seizure clusters is needed.    
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Introduction 
Seizure cluster is defined as a closely grouped series of seizures 1. There is no universally 
accepted definition for a cluster of seizures and published studies have used varying definitions, 
including two to four seizures per < 48 hours; 3 seizures per 24 hours; or having several 
convulsions within a day or two 1. Seizure clustering in patients with epilepsy is a relatively 
common phenomenon with a reported prevalence ranging from 20% to 30% in some previous 
studies 2, 3. Seizure clusters may impose significant risks to patients with epilepsy. They were 
associated with status epilepticus, hospitalizations, and worse seizure control 3. Whether a 
pattern of seizure clustering influences seizure outcome after surgery for drug-resistant seizures 
in patients with focal epilepsy is not known.    
It is important to investigate the clinical features associated with seizure clusters as this may help 
elucidate the underlying pathophysiology. Similarly, it is desirable to know whether seizure 
clusters relate to seizure outcome after surgery for drug-resistant seizures. We address these two 
issues in the present investigation.    
 
Methods 
We performed a retrospective study including patients with a diagnosis of drug-resistant focal 
epilepsy who underwent epilepsy surgery at Jefferson Comprehensive Epilepsy Center. Adult 
and adolescent patients (above 10 years of age) were prospectively registered in a database from 
1986 until 2015. The diagnosis of epilepsy was made by the epileptologists working at this 
institution. Individuals with progressive neurological disease, malignant brain tumors, or 
psychogenic nonepileptic seizures were excluded. Patients had a comprehensive presurgical 
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evaluation including a brain MRI, scalp video-EEG monitoring, neuropsychological testing, and 
other appropriate testing as clinically indicated 4. All patients had resective brain surgery. 
Patients were followed for up to five years after surgery (in many patients data were missing 
beyond five years of follow-up for a valid analysis). Seizure cluster was defined as two or more 
seizures occurring within two days, in a habitual pattern (i.e., not only in response to medication 
withdrawal or concurrent illness) that was also distinguishable from more sporadic usual 
seizures. It was derived from the written histories obtained by physicians and encoded in the 
database as “Yes/No”. Seizure outcome was obtained during office visits, telephone contact, and 
by letter. Postsurgical outcome was classified into two groups: no recurrence of complex partial 
(CPS) or secondarily generalized seizures (though auras could recur) or relapse of CPS or 
secondarily generalized seizures at any time after surgery. Age, gender, race, epilepsy risk 
factors [e.g., history of febrile seizures in childhood, any family history of epilepsy, etc.], age at 
seizure onset, seizure type(s) and history, date of surgery, date of the first relapse (if any) and 
date of the last contact with all patients were registered routinely.   
Potential risk factors for seizure clustering (i.e., gender, age at surgery, duration of epilepsy, 
history of tonic-clonic seizures before surgery, history of febrile seizures in childhood, family 
history of epilepsy, full scale intelligence quotient (IQ), preoperative auras, and MRI findings) 
were assessed comparing patients who had clusters and those who did not have clusters. We 
performed Pearson Chi-square, Mann-Whitney, Kolmogorov-Smirnov, and t-test depending 
upon the circumstance. To investigate any potential association between seizure clusters and 
outcome after surgery, time to event analysis was used to produce a Kaplan-Meier estimate of 
seizure recurrence. The Cox-Mantel test was used to compare the cumulative time-dependent 
probability of occurrence of the first seizure after resective epilepsy surgery in patients with and 
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without clusters. In a subanalysis, we investigated the rate of seizure freedom in the last year of 
follow-up in patients with at least two years of postoperative follow-up. We classified the 
patients as seizure free if they had no CPS or secondarily generalized seizures for the last year of 
follow-up. P values less than 0.05 were considered as significant.  
Thomas Jefferson University Institutional Review Board approved this retrospective record 
review and database study. No informed consent was required, as it was a retrospective study.   
 
Results 
From 1986 until 2015, 1225 patients had epilepsy surgery; 978 patients had data on preoperative 
seizure clustering available; data was missing for 247 patients. Of the 978 patients included in 
this analysis, 681 (69.6%) had temporal lobe surgery and 83 (8.5%) had extratemporal surgery 
and were included in this analysis; we excluded 214 patients who had corpus callosotomy, vagus 
nerve stimulation, or multilobar resections with both temporal and extratemporal resection. The 
proportion of temporal resections among patients with missing data was similar to the studied 
group [of 247 patients with missing data, 161 (65.2%) had temporal lobe surgery (p = 0.1)]. 
However, relatively more patients with missing data had extratemporal surgery [39 (15.8%) 
patients; p = 0.0001]. 
Among patients with temporal lobe epilepsy (TLE), 161 (23.6%) experienced seizure clusters 
and among extratemporal epilepsy patients, 14 (16.9%) reported such an experience (p = 0.2). 
Among patients with extratemporal surgery, having seizure clusters were not significantly 
different between patients with frontal lobe surgery (10 out of 60) compared with those with only 
parietal or occipital lobe surgery (4 out of 23); p = 1. We could not identify any significant 
clinical associations for experiencing seizure clusters for the entire cohort (Table 1). Similarly, 
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we could not identify any significant associations with clusters for TLE patients (all p values 
were above 0.06). In patients with TLE, neither side of surgery nor presence or absence of mesial 
temporal sclerosis (MTS) was associated with seizure clustering. Among patients with seizure 
clusters, 41 patients had normal MRI, 66 had MTS, and 52 had other lesions (2 MRIs were 
missing). Among patients with no seizure clusters, these figures were 105, 237, and 161, 
respectively (17 MRIs were missing) (p = 0.3). There was no difference in the need for 
intracranial EEG recordings in patients with seizure clusters (21 out of 175) versus those without 
seizure clusters (87 out of 589) in the entire cohort (p = 0.3). 
Next, we studied whether seizure clusters related to seizure outcome after focal resective 
epilepsy surgery. Among patients with TLE, those with a history of seizure clusters fared better 
after surgery than those patients who did not have clusters (p = 0.005) (Fig 1). In patients with 
extratemporal epilepsy we did not observe such an association (p = 0.09).   
 
Discussion 
Seizure clusters are relatively common phenomena among patients with epilepsy, particularly 
among those with drug-resistant seizures. About one fifth of our patients displayed this tendency. 
While we could not identify any distinct associations between seizures clusters and particular 
clinical or historical features, we observed that a history of seizure clusters was associated with a 
better seizure outcome after temporal lobe surgery. One of the most important risk factors 
associated with worse outcome after surgery for drug-resistant TLE is a history of preoperative 
tonic-clonic seizures 5. In the current study, the prevalence of preoperative tonic-clonic seizures 
was similar in patients with and without seizure clusters, so clustering appears to be an 
independent prognostic factor. Hence, seizure clusters are a marker that the primary 
7 
 
epileptogenic zone is more likely to be located in anterior and mesial temporal structures. More 
patients with extratemporal epilepsy need to be studied before firm conclusions can be drawn 
about the relationship between seizure clusters and postsurgical outcome.  
Why seizures cluster is uncertain. We did not investigate the neurobiological underpinnings of 
seizure clusters in this study. However, previous studies suggest that it is possible that 
endogenous hormone fluctuations may lead to periods of enhanced seizure susceptibility and 
other periods with greater resistance to seizure recurrence 6. Periods of enhanced susceptibility 
might then have more seizures, appearing as clusters. For example, the density of dendritic 
spines on hippocampal pyramidal cells is dependent on circulating estradiol and progesterone 
and fluctuates naturally during the estrous cycle in female rats. Changes in dendritic spine 
density during the estrous cycle are likely to have consequences for hippocampal neuronal 
excitability 7.  Other endogenous hormones could have similar effects. Hence, the cycling of 
seizures may correspond to these structural changes.  
Because, seizure clustering may impose significant risks to patients, identifying the potential 
clinical associations is important. While we could not identify any associations or risk factors 
associated with seizure clustering, a previous study found that head trauma and extratemporal 
epilepsy were associated with seizure clusters 3. Unfortunately, our database did not contain 
reliable descriptions of head trauma, so we could not assess this relationship. We could not 
replicate the previously reported association of extratemporal epilepsy with seizure clusters. In 
another study 8, age at epilepsy onset was lower in cluster patients than in the non-cluster 
patients.  We could not replicate this findings either. Given the lack of clear clinical associations, 
future efforts are probably better devoted to investigating other features that might shed light on 
the neurobiology of seizure clusters.   
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How seizure clusters are defined 9 might influence data collection, data interpretation, and study 
results, which is a potential limitation of this study. Any definition of seizure clusters is of 
necessity arbitrary and clusters probably exist along a spectrum with occurrence possibly 
influenced by the underlying neurobiology of seizures, medications, and other factors. We have 
used a broad definition to account for the clinical picture, and recognize that a stricter definition 
requiring seizures to occur over a period of a few hours might yield different results. Another 
limitation of this study is the reliability of the history of seizure clusters, as it was a retrospective 
study and recall bias is a potential limitation. Patients who were not seizure-free after surgery 
were not systematically re-assessed to explain the reasons for postsurgical failure. These reasons 
are likely to be different in people with temporal and extratemporal epilepsies, which could be a 
confounder of this study, but there were unlikely to be systematic differences in extent of 
resection or other features that would otherwise explain the difference. Furthermore, we did not 
take into account other factors that may impact postoperative outcome 10-13. Finally, our findings 
may not apply to the overall group of patients with uncontrolled seizures, as we had a special 
subgroup of patients with drug-resistant focal epilepsy requiring surgery. Our findings apply to 
the patients who had anterior temporal lobectomy for drug-resistant temporal lobe epilepsy and 
not to other populations. 
In brief, we found that seizure clusters relate to prognosis after anterior temporal lobectomy in 
drug-resistant TLE. This data may provide added value for surgical prognostication when 
combined with other data types 5, 10-13. A better understanding of the neurobiology underlying 
seizure clusters is needed.    
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Figure 1. Kaplan-Meier graph showing cumulative time-dependent probability of occurrence of 
the first seizure after resective epilepsy surgery in patients with temporal lobe epilepsy, with or 
without preoperative seizure clusters.  
 
Figure 1 legend. Postoperative seizure outcome was better in patients with drug-resistant 
temporal lobe epilepsy who had history of preoperative seizure clusters. 
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Table 1. Clinical factors in association with seizure clusters 
 
Clinical characteristic 
Patients with  
Seizure clusters 
(N=175) * 
Patients without  
Seizure clusters 
(N=589) * 
 
P 
value 
Sex ratio (Male / Female) 93 / 82 284 / 305 0.2 
History of childhood febrile seizure 46  148  0.8 
Family history of epilepsy 49  181  0.5 
Aura (none/ epigastric / auditory / 
mnemonic / affective / others / multiple) 
40 / 28 / 2 / 11 / 12 / 
56 / 23 
197 / 85 / 17 / 37 / 24 
/ 167 / 58 
0.08 
Remote history of tonic-clonic seizures 
(not within the past year) 
48  159  0.9 
Recent history of tonic-clonic seizures 
(within the past year) 
51  207  0.1 
Age at epilepsy onset (years) 15 ± 11.1 15.8 ± 12.4 0.4 
Disease duration (years) 18.8 ± 11.5 19.7 ± 11.7 0.3 
Full scale IQ 93 ± 18 92 ± 15 0.3 
*Some data were missing. 
 
